Cargando…
Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
Autores principales: | Kobayashi, Tetsu, Hataji, Osamu, Fujimoto, Hajime, D’Alessandro-Gabazza, Corina, Yasuma, Taro, Gabazza, Esteban C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258634/ https://www.ncbi.nlm.nih.gov/pubmed/32150439 http://dx.doi.org/10.1164/rccm.202002-0271LE |
Ejemplares similares
-
No Strong Evidence for Ruling Out the Role of Coagulation in Long-Term Disability after Critical Illness
por: Yasuma, Taro, et al.
Publicado: (2021) -
Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020) -
Response of Lung Microbiota to Changes of Pulmonary Innate Immunity under Healthy Conditions
por: Yasuma, Taro, et al.
Publicado: (2021) -
The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022) -
Microbial Burden-associated Cytokine Storm May Explain Nonresolving Acute Respiratory Distress Syndrome in Patients with COVID-19
por: Yasuma, Taro, et al.
Publicado: (2022)